Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences
Fast-acting insulin aspart (faster aspart) is insulin aspart (IAsp) with two added excipients, L-arginine and niacinamide, to ensure formulation stability with accelerated initial absorption after subcutaneous administration compared with previously developed rapid-acting insulins. The pharmacokinet...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN RU |
| Publié: |
Endocrinology Research Centre
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/8f6ea16d2b274e568069cac42f9f1865 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|